Literature DB >> 36105011

A nomogram for prediction of distant metastasis in patients with hypopharyngeal squamous cell carcinoma: a study based on the SEER database.

Xiaozhu Liu1, Shuchen Wang2, Wenling Wu3, Jian Zhang4, Shengxian Peng5.   

Abstract

BACKGROUND: The prognosis of hypopharyngeal squamous cell carcinoma (HPSCC) is poor due to its high incidence of local invasion and distant metastasis (DM). This study aims to explore the DM risk factors of HPSCC and establish a clinical prediction model.
METHODS: We downloaded patient data from the Public Surveillance, Epidemiology, and End Results (SEER) database between 2004 and 2018. Univariate and multivariate logistic regression analyses were performed to screen the clinical risk factors for DM of HPSCC. A new nomogram prediction model was then established based on the selected clinical risk factors. We further validated the model's accuracy based on the concordance index (C-index), the area under the receiver operating characteristic (AUC) curve, and the calibration plot. The decision curve analysis (DCA) to test the potential clinical value of the new model was also applied.
RESULTS: A total of 3502 patients were enrolled; the patients with HPSCC were randomly assigned to a training set (n=2463) and a validation set (n=1039). Multivariate Logistic model analysis suggested that sex, T stage, N stage, and the total number of tumors were influence factors for DM of HPSCC. We established and validated a novel nomogram prediction model based on the multivariate logistic model with these influence factors. The C-index was 0.943 and 0.849 in the training and validation sets respectively. The AUC of the training set was 0.705 (95% CI: 0.669-0.741), and the validation set was 0.667 (95% CI: 0.609-0.725). The calibration plot shows that the actual observation value was similar to the predicted value, meaning the model has an excellent discrimination ability. DCA of the nomogram in the training and validation sets suggested that our nomogram has potential application value.
CONCLUSIONS: We found that sex, T stage, N stage, and the total number of tumors are independent risk factors for DM of HPSCC. We developed a novel prediction model to predict DM in patients with HPSCC. This nomogram can identify patients with a high risk of DM and has a high clinical application value. AJTR
Copyright © 2022.

Entities:  

Keywords:  Nomogram; SEER; distant metastasis; hypopharyngeal; squamous cell carcinoma

Year:  2022        PMID: 36105011      PMCID: PMC9452331     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  26 in total

1.  Towards better clinical prediction models: seven steps for development and an ABCD for validation.

Authors:  Ewout W Steyerberg; Yvonne Vergouwe
Journal:  Eur Heart J       Date:  2014-06-04       Impact factor: 29.983

2.  Hypopharyngeal cancer: looking back, moving forward.

Authors:  D Day; A R Hansen; L L Siu
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

Review 3.  Incidence and sites of distant metastases from head and neck cancer.

Authors:  A Ferlito; A R Shaha; C E Silver; A Rinaldo; V Mondin
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2001 Jul-Aug       Impact factor: 1.538

4.  Metastatic patterns in squamous cell cancer of the head and neck.

Authors:  C Kotwall; K Sako; M S Razack; U Rao; V Bakamjian; D P Shedd
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

Review 5.  Current management strategy of hypopharyngeal carcinoma.

Authors:  Jimmy Yu Wai Chan; William Ignace Wei
Journal:  Auris Nasus Larynx       Date:  2012-06-17       Impact factor: 1.863

6.  Distant metastases in head and neck cancer.

Authors:  Fréderic Duprez; Dieter Berwouts; Wilfried De Neve; Katrien Bonte; Tom Boterberg; Philippe Deron; Wouter Huvenne; Sylvie Rottey; Marc Mareel
Journal:  Head Neck       Date:  2017-06-26       Impact factor: 3.147

7.  Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.

Authors:  X Li; B Di; Y Shang; Y Zhou; J Cheng; Z He
Journal:  Eur J Surg Oncol       Date:  2009-07-18       Impact factor: 4.424

8.  Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy.

Authors:  Ryo-ichi Yoshimura; Yoshikazu Kagami; Yoshinori Ito; Masao Asai; Hiroshi Mayahara; Minako Sumi; Jun Itami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-10       Impact factor: 7.038

9.  Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).

Authors:  C Domenge; C Hill; J L Lefebvre; D De Raucourt; B Rhein; P Wibault; P Marandas; B Coche-Dequeant; M Stromboni-Luboinski; H Sancho-Garnier; B Luboinski
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.

Authors:  Xin Tang; Tong Pang; Wei-Feng Yan; Wen-Lei Qian; You-Ling Gong; Zhi-Gang Yang
Journal:  BMC Cancer       Date:  2020-11-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.